摘要
Purpose: Data are extremely limited with regards to the impact of COVID-19 on cancer patients. Our study explored the distinct clinical features of COVID-19 patients with cancer. @@@ Experimental Design: 189 COVID-19 patients, including 16 cancer patients and 173 patients without cancer, were recruited. Propensity score 1:4 matching (PSM) was performed between cancer patients and patients without cancer based on age, gender and comorbidities. Survival was calculated by the Kaplan-Meier method and the difference was compared by the log-rank test. @@@ Results: PSM analysis yielded 16 cancer patients and 64 propensity score-matched patients without cancer. Compared to patients without cancer, cancer patients tended to have leukopenia and elevated high-sensitivity C-reactive protein (hs-CRP) and procalcitonin. For those with critical COVID-19, cancer patients had an inferior survival than those without cancer. Also, cancer patients with severe/critical COVID-19 tended to be male and present with low SPO2 and albumin, and high hs-CRP, lactate dehydrogenase and blood urea nitrogen on admission compared to those with mild COVID-19. In terms of risk factors, recent cancer diagnosis (within 1 year of onset of COVID-19) and anti-tumor treatment within 3 months of COVID-19 diagnosis were associated with inferior survival. @@@ Conclusions: We found COVID-19 patients with cancer have distinct clinical features as compared to patients without cancer. Importantly, cancer patients with critical COVID-19 were found to have poorer outcomes compared to those without cancer. In the cancer cohort, patients with severe/critical COVID-19 presented with a distinct clinical profile from those with mild COVID-19; short cancer history and recent anti-cancer treatment were associated with inferior survival.
学科与关键词
- Increased risk of COVID-19-related admissions in patients with active solid organ cancer in the West Midlands region of the UK: a retrospective cohort studyAkingboye, Akinfemi; Mahmood, Fahad; Amiruddin, Nabeel; Reay, Michael; Nightingale, Peter; Ogunwobi, Olorunseun O.*BMJ Open, 2021, 11(12): e053352.被引 2
- Association of COVID-19 and Lung Cancer: Short-Term and Long-Term InteractionsPeng, Ying-Long; Wang, Zi-Yan; Zhong, Ri-Wei; Mei, Shi-Qi; Liu, Jia-Qi; Tang, Li-Bo; Guo, Zhi; Ren, Zi-Rui; Wu, Lv; Deng, Yu; Chen, Zhi-Hong; Zhou, Qing; Xu, Chong-Rui*Cancers, 2024, 16(2): 304.
- High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable PrognosisWang, Qianqian; Li, Liangyu; Qu, Tianyu; Li, Jie; Wu, Lingxiang; Li, Kening; Wang, Ziyu; Zhu, Mengyan; Huang, Bin; Wu, Wei; Wu, Min; Ding, Rong; Zhang, Zhihong; Wang, Qianghu; Xia, Xinyi*; Li, Pengping*; Zhang, Zhi; Guo, Renhua*Frontiers in Oncology, 2021, 11: 644575.被引 11
